Journal Names

BindingDB Data by Journal

Journal Volume Page

PMID	Data	Article Title	Citation	Organization	Data Download
WO2005113580A1	101	Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis	WIPO 0: 0-0 (2005)	Pfizer Inc.	2D 3D TSV
WO2022081973	137	PHOSPHOLIPID COMPOUNDS AND USES THEREOF	WIPO 0: 0-0 (2022)	GILEAD SCIENCES, INC.	2D 3D TSV
WO2021205290A1	52	Compounds and method of treating covid-19	WIPO 0: 0-0 (2021)	Pfizer Inc.	2D 3D TSV
WO2021205298A1	15	Compounds and methods for the treatment of covid-19	WIPO 0: 0-0 (2021)	Pfizer Inc.	2D 3D TSV
WO2021250648A1	170	Nitrile-containing antiviral compounds	WIPO 0: 0-0 (2021)	Pfizer Inc.	2D 3D TSV
WO2021219089A1	190	Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections	WIPO 0: 0-0 (2021)	Insilico Medicine Ip Limited	2D 3D TSV
WO2022064009	299	CYCLIN-DEPENDENT KINASE 7 (CDK7) NON-COVALENT INHIBITORS	WIPO 0: 0-0 (2022)	JANSSEN PHARMACEUTICA NV	2D 3D TSV
WO2022043374A1	136	Aminocarbamoyl compounds for the treatment of viral infections	WIPO 0: 0-0 (2022)	F. Hoffmann-La Roche Ag	2D 3D TSV
WO2022086828	792	TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS	WIPO 0: 0-0 (2022)	BRISTOL-MYERS SQUIBB COMPANY	2D 3D TSV
WO2022070069	6	DIHYDROOROTATE DEHYDROGENASE INHIBITORS	WIPO 0: 0-0 (2022)	JANSSEN BIOTECH, INC.	2D 3D TSV
WO2022076495	144	PREPARATION OF BENZIMIDAZOLONE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS	WIPO 0: 0-0 (2022)	MERCK SHARP & DOHME CORP.	2D 3D TSV
WO2022070068	29	DIHYDROOROTATE DEHYDROGENASE INHIBITORS	WIPO 0: 0-0 (2022)	JANSSEN BIOTECH, INC.	2D 3D TSV
WO2022070071	8	DIHYDROOROTATE DEHYDROGENASE INHIBITORS	WIPO 0: 0-0 (2022)	JANSSEN BIOTECH, INC.	2D 3D TSV
WO2022076764	166	AMINOIMIDAZOLE FPR2 AGONISTS	WIPO 0: 0-0 (2022)	BRISTOL-MYERS SQUIBB COMPANY	2D 3D TSV
WO2022076496	170	PREPARATION OF OXINDOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 INHIBITORS	WIPO 0: 0-0 (2022)	MERCK SHARP & DOHME CORP.	2D 3D TSV
WO2022079616	44	COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS	WIPO 0: 0-0 (2022)	NOVARTIS AG	2D 3D TSV
WO2022081807	252	SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER	WIPO 0: 0-0 (2022)	THE BROAD INSTITUTE, INC.	2D 3D TSV
WO2022081842	96	SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER	WIPO 0: 0-0 (2022)	THE BROAD INSTITUTE, INC.	2D 3D TSV
WO2006061714A2	12	Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis	WIPO 0: 0-0 (2006)	Pfizer Inc.	2D 3D TSV